Cargando…

Reactive infectious mucocutaneous eruption secondary to SARS-CoV-2

Detalles Bibliográficos
Autores principales:	Ryder, C. Yoonhee, Pedersen, Elisabeth A., Mancuso, Jennifer B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8527593/ https://www.ncbi.nlm.nih.gov/pubmed/34692963 http://dx.doi.org/10.1016/j.jdcr.2021.10.007

Ejemplares similares

This Month in JAAD Case Reports: March 2022. Reactive infectious mucocutaneous eruption secondary to SARS-CoV-2
por: Sloan, Brett
Publicado: (2022)

Severe recurrence of reactive infectious mucocutaneous eruption with extensive ocular involvement in an adult due to SARS-CoV-2
por: Wu, David, et al.
Publicado: (2023)

Reactive infectious mucocutaneous eruption following COVID-19 infection in vaccinated patients
por: Aw, Michael, et al.
Publicado: (2022)

Reactive infectious mucocutaneous eruption in children diagnosed with COVID‐19
por: Bowe, Stephanie, et al.
Publicado: (2021)

Clinical and microbiological characteristics of reactive infectious mucocutaneous eruption: A case series of 5 patients
por: Vassallo, Camilla, et al.
Publicado: (2021)

Reactive infectious mucocutaneous eruption – repeat etanercept after intravenous immunoglobulin: A case report
por: Tonkin, Rochelle, et al.
Publicado: (2022)

Recurrent Mycoplasma pneumoniae–associated reactive infectious mucocutaneous eruption responsive to systemic steroids: A case series
por: Maredia, Hasina, et al.
Publicado: (2021)

Evolving mucocutaneous eruptions following chemotherapy
por: Chen, Ailynna, et al.
Publicado: (2022)

Mucocutaneous lesions associated with SARS-CoV-2 infection (Review)
por: Toader, Mihaela Paula, et al.
Publicado: (2022)

A Case Series of Mucocutaneous Mucormycosis and its Risk Factors among SARS-CoV-2 Patients
por: Arora, Aakanksha, et al.
Publicado: (2022)

Cutaneous Eruption after SARS-CoV-2 Vaccine in Psoriatic Patient Treated with Methotrexate
por: Serena, Lembo, et al.
Publicado: (2022)

Prurigo Nodularis Eruption Triggered by SARS-CoV-2 Vaccine
por: Barnawi, Ghassan, et al.
Publicado: (2022)

Mucocutaneous manifestations among adults hospitalized with multisystem inflammatory syndrome following SARS-CoV-2 infection
por: Tannenbaum, Rachel, et al.
Publicado: (2022)

Onycho-mucocutaneous syndrome secondary to human immunodeficiency virus disease
por: Madhuri, B., et al.
Publicado: (2021)

Pseudo-Pemphigoid Gestationis Eruption Following SARS-CoV-2 Vaccination with mRNA Vaccine
por: de Lorenzi, Caroline, et al.
Publicado: (2022)

An acneiform eruption secondary to iododerma
por: Hesseler, Michael J., et al.
Publicado: (2018)

SARS-CoV-2: too infectious to handle?
por: Coveney, Clarissa, et al.
Publicado: (2020)

New drugs, new challenges for dermatologists: mucocutaneous ulcers secondary to everolimus
por: Pasin, Victor Pavan, et al.
Publicado: (2015)

Extensive mucocutaneous, oesophageal and otic lichen planus secondary to nivolumab therapy
por: Ferguson, L., et al.
Publicado: (2020)

Hemophagocytic lymphohistiocytosis secondary to histoplasmosis: A case report in a patient with AIDS and recent SARS-CoV-2 infection and minireview
por: Pipitò, Luca, et al.
Publicado: (2023)

Reactivation of cutaneous and mucocutaneous tegumentary leishmaniasis in rheumatoid arthritis patients: an emerging problem?
por: de Souza, Regina Maia, et al.
Publicado: (2017)

Severe Cholestatic Hepatitis Secondary to SARS-CoV-2
por: Lindholm, Christopher R., et al.
Publicado: (2022)

Rituximab: Reactivation of SARS-CoV-2 infection: case report
Publicado: (2021)

Rituximab: Reactivation of SARS-CoV-2 infection: case report
Publicado: (2021)

Reactive arthritis after SARS-CoV-2 infection
por: Sureja, Nayan Patel, et al.
Publicado: (2021)

Novel signaling pathways regulate SARS-CoV and SARS-CoV-2 infectious disease
por: Cheng, Li-Chin, et al.
Publicado: (2021)

Mucocutaneous manifestations of Cowden's syndrome
por: Reddy, Kundoor Vinay Kumar, et al.
Publicado: (2016)

Mucocutaneous Paraneoplastic Syndrome Secondary to Classical Hodgkin’s Lymphoma
por: Jurkovic, Jenna, et al.
Publicado: (2019)

Reinfection and reactivation of SARS-CoV-2
por: Dowran, Razieh, et al.
Publicado: (2022)

The great pretender—Bell’s palsy secondary to SARS‐CoV‐2?
por: Neo, Wei Li, et al.
Publicado: (2021)

Cerebral Sinus Thrombosis Secondary to SARS-CoV-2 Infection
por: Khazaei, Mojtaba, et al.
Publicado: (2021)

Mycotic clival osteomyelitis secondary to immunosuppression by SARS-CoV-2
por: Delgado-Arce, Julio César, et al.
Publicado: (2022)

Éruption urticarienne et infection au SARS-CoV-2 : un diagnostic tardif
por: Demay, Jonathan, et al.
Publicado: (2020)

SARS-CoV-2 late shedding may be infectious between immunocompromised hosts
por: Kaila, Ville, et al.
Publicado: (2021)

Reactivation of Acute Retinal Necrosis following SARS-CoV-2 Infection
por: Gonzalez, Monica P., et al.
Publicado: (2021)

Airborne spread of infectious SARS-CoV-2: Moving forward using lessons from SARS-CoV and MERS-CoV
por: da Silva, Priscilla Gomes, et al.
Publicado: (2021)

Varicella Zoster Aseptic Meningitis Presenting as an Atypical Mucocutaneous Eruption Involving All Three Divisions of the Trigeminal Nerve
por: Magazin, Maja, et al.
Publicado: (2022)

Cross-reactivity of SARS-CoV structural protein antibodies against SARS-CoV-2
por: Bates, Timothy A., et al.
Publicado: (2020)

Cross-reactive antibody response between SARS-CoV-2 and SARS-CoV infections
por: Lv, Huibin, et al.
Publicado: (2020)

Cross-reactive Antibody Response between SARS-CoV-2 and SARS-CoV Infections
por: Lv, Huibin, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_5ja4s98p4ro7t3hloch5jp02mf